Penile Cancer Clinical Trial
Official title:
Phase II Study of Irinotecan (CPT 11) and Cisplatin (CDDP) in Metastatic or Locally Advanced Penile Carcinoma
RATIONALE: Drugs used in chemotherapy such as irinotecan and cisplatin use different ways to
stop tumor cells from dividing so they stop growing or die. Combining irinotecan with
cisplatin may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combining irinotecan with cisplatin in
treating patients who have locally advanced or metastatic penile cancer.
OBJECTIVES:
- Determine the anticancer activity of irinotecan and cisplatin in patients with locally
advanced or metastatic penile cancer.
- Determine the objective response rate and duration of response in patients treated with
this regimen.
- Determine the acute side effects of this regimen in these patients.
OUTLINE: This is an open-label, nonrandomized, multicenter study.
Patients receive irinotecan IV over 30 minutes on days 1, 8, and 15 and cisplatin IV over
1-3 hours on day 1. Courses repeat every 28 days in the absence of disease progression or
unacceptable toxicity. Patients not undergoing local treatment receive up to 8 courses.
Patients planning to undergo surgery receive up to 4 courses.
Patients are followed every 8 weeks until disease progression and then every 3 months
thereafter.
PROJECTED ACCRUAL: A total of 13-28 patients will be accrued for this study.
;
Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03686332 -
PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study
|
Phase 2 | |
| Completed |
NCT05518201 -
Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old
|
Phase 1 | |
| Recruiting |
NCT04708470 -
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT04357873 -
Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations
|
Phase 2 | |
| Terminated |
NCT00058448 -
S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)
|
Phase 2 | |
| Recruiting |
NCT02817958 -
Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penis
|
Phase 2 | |
| Completed |
NCT02280811 -
T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers
|
Phase 2 | |
| Recruiting |
NCT02994758 -
Development of Diagnostics and Treatment of Urological Cancers
|
N/A | |
| Completed |
NCT00019110 -
Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer
|
Phase 1 | |
| Completed |
NCT04574427 -
INtra-operative Evaluation of a Novel FLUorescENt C-mEt Tracer in Penile and Tongue
|
||
| Recruiting |
NCT02012699 -
Integrated Cancer Repository for Cancer Research
|
||
| Recruiting |
NCT05946993 -
Linking In With Advice and Supports for Men Impacted by Metastatic Cancer
|
N/A | |
| Recruiting |
NCT04028479 -
The Registry of Oncology Outcomes Associated With Testing and Treatment
|
||
| Recruiting |
NCT05686226 -
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
|
Phase 2 | |
| Completed |
NCT05376202 -
Image Guided Penile Cancer Surgery
|
Phase 1 | |
| Recruiting |
NCT05264337 -
Lymphedema After Urologic Surgery
|
||
| Recruiting |
NCT03774901 -
Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile Carcinoma
|
Phase 2 | |
| Completed |
NCT01209325 -
Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males
|
Phase 2 | |
| Recruiting |
NCT05592639 -
VideoEndoscopic Radical Inguinal Lymphadenectomy for Penile Cancer
|
N/A | |
| Not yet recruiting |
NCT06353906 -
Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer
|
Phase 2 |